Elite Pharmaceuticals, Inc. (ELTP)
0.349
0.00 (0.00%)
USD |
OTCM |
May 04, 16:00
Elite Pharmaceuticals Market Cap : 375.87M for May 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Glaukos Corp. | 7.979B |
| cbdMD, Inc. | 8.983M |
| ACADIA Pharmaceuticals, Inc. | 3.783B |
| Alnylam Pharmaceuticals, Inc. | 39.78B |
| Savara, Inc. | 1.085B |
Market Cap Related Metrics
| PE Ratio | 16.08 |
| PS Ratio | 2.752 |
| Price to Book Value | 4.680 |
| Price to Free Cash Flow | 22.37 |
| Price | 0.349 |
| Earnings Yield | 6.22% |
| Operating PE Ratio | 7.460 |
| Normalized PE Ratio | 17.45 |